Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Hemperly

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Pharmacokinetics|January 14, 2018
Clinical Pharmacokinetics and Pharmacodynamics of Infliximab in the Treatment of Inflammatory Bowel DiseaseAmy Hemperly, Niels Vande Casteele
Inflammatory Bowel Diseases|May 23, 2018
Clinical Pharmacology in Adult and Pediatric Inflammatory Bowel DiseaseAmy Hemperly, William J Sandborn, Niels Vande Casteele
Journal of Clinical Medicine|November 27, 2025
Pharmacokinetics and Exposure-Response During Infliximab Induction Therapy in Pediatric IBD Using Point-of-Care AssayAmy Hemperly, Jincheng Yang, Anh Ta, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 30, 2020
Baseline Clearance of Infliximab Is Associated With Requirement for Colectomy in Patients With Acute Severe Ulcerative ColitisRobert Battat, Amy Hemperly, Stephanie Truong, et al.
Crohn'S & Colitis 360|February 13, 2023
Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug MonitoringAmy Hemperly, Marla C Dubinsky, Andres Yarur, et al.
Crohn'S & Colitis 360|December 16, 2024
Predictive Model for Outcomes in Inflammatory Bowel Disease Patients Receiving Maintenance Infliximab TherapyRochelle Wong, Paris Charilaou, Amy Hemperly, et al.
Nature|December 5, 2023
Reverse metabolomics for the discovery of chemical structures from humansEmily C Gentry, Stephanie L Collins, Morgan Panitchpakdi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Pharmacokinetics|January 14, 2018
Clinical Pharmacokinetics and Pharmacodynamics of Infliximab in the Treatment of Inflammatory Bowel DiseaseAmy Hemperly, Niels Vande Casteele
Inflammatory Bowel Diseases|May 23, 2018
Clinical Pharmacology in Adult and Pediatric Inflammatory Bowel DiseaseAmy Hemperly, William J Sandborn, Niels Vande Casteele
Journal of Clinical Medicine|November 27, 2025
Pharmacokinetics and Exposure-Response During Infliximab Induction Therapy in Pediatric IBD Using Point-of-Care AssayAmy Hemperly, Jincheng Yang, Anh Ta, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 30, 2020
Baseline Clearance of Infliximab Is Associated With Requirement for Colectomy in Patients With Acute Severe Ulcerative ColitisRobert Battat, Amy Hemperly, Stephanie Truong, et al.
Crohn'S & Colitis 360|February 13, 2023
Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug MonitoringAmy Hemperly, Marla C Dubinsky, Andres Yarur, et al.
Crohn'S & Colitis 360|December 16, 2024
Predictive Model for Outcomes in Inflammatory Bowel Disease Patients Receiving Maintenance Infliximab TherapyRochelle Wong, Paris Charilaou, Amy Hemperly, et al.
Nature|December 5, 2023
Reverse metabolomics for the discovery of chemical structures from humansEmily C Gentry, Stephanie L Collins, Morgan Panitchpakdi, et al.
Pageof 1